ArticleScientific reports2024

Comprehensive analysis of Epha10 as a predictor of clinical prognosis and immune checkpoint therapy efficacy in non-small cell lung cancer.

Anqi Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.